In conclusion, we confirmed the role of PNPLA3, TM6SF2, GCKR and MBOAT7 gene variants as genetic determinants of NAFLD and we suggested a weighted GRS based on their additive and combined effect. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.